Selection of treatment for patients with early stage non-small cell Lung cancer in a multidisciplinary thoracic oncology program

Stuart M. Berman, Mark Huberman, Armin Ernst, David Feller-Kopman, David H. Roberts, Phillip Boiselle, J. Anthony Parker, Danielle McDonald, Nancy Rumplik, Elena A. Nedea, Simon Ashiku, Sidhu P. Gangadharan, Michael Goldstein, Susan Schumer, Sanjay R. Jain, Darren Brennan, Michael S. Buff, Robert L. Thurer, Malcolm Decamp

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Lung cancer is the leading cause of cancer mortality in men and women. More than 170,000 Americans receive a diagnosis of lung cancer annually and the majority of them die of the disease [1]. There is considerable interest in improving treatment for lung cancer given its high impact on society. More than 80% of patients with lung cancer have non-small cell carcinoma (NSCLC). Surgery is the mainstay of treatment for patients with early stage NSCLC and results in cure of about 60-80% of patients with stage I (T1-2N0) disease [2]-[5].

Original languageEnglish (US)
Title of host publicationTreating Tumors that Move with Respiration
PublisherSpringer Berlin Heidelberg
Pages133-144
Number of pages12
ISBN (Print)9783540698852
DOIs
StatePublished - Dec 1 2007

Fingerprint

Non-Small Cell Lung Carcinoma
Patient Selection
Lung Neoplasms
Thorax
Carcinoma
Therapeutics
Mortality
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Berman, S. M., Huberman, M., Ernst, A., Feller-Kopman, D., Roberts, D. H., Boiselle, P., ... Decamp, M. (2007). Selection of treatment for patients with early stage non-small cell Lung cancer in a multidisciplinary thoracic oncology program. In Treating Tumors that Move with Respiration (pp. 133-144). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-69886-9_15
Berman, Stuart M. ; Huberman, Mark ; Ernst, Armin ; Feller-Kopman, David ; Roberts, David H. ; Boiselle, Phillip ; Parker, J. Anthony ; McDonald, Danielle ; Rumplik, Nancy ; Nedea, Elena A. ; Ashiku, Simon ; Gangadharan, Sidhu P. ; Goldstein, Michael ; Schumer, Susan ; Jain, Sanjay R. ; Brennan, Darren ; Buff, Michael S. ; Thurer, Robert L. ; Decamp, Malcolm. / Selection of treatment for patients with early stage non-small cell Lung cancer in a multidisciplinary thoracic oncology program. Treating Tumors that Move with Respiration. Springer Berlin Heidelberg, 2007. pp. 133-144
@inbook{75a24db62efb46cea2692a9874a00032,
title = "Selection of treatment for patients with early stage non-small cell Lung cancer in a multidisciplinary thoracic oncology program",
abstract = "Lung cancer is the leading cause of cancer mortality in men and women. More than 170,000 Americans receive a diagnosis of lung cancer annually and the majority of them die of the disease [1]. There is considerable interest in improving treatment for lung cancer given its high impact on society. More than 80{\%} of patients with lung cancer have non-small cell carcinoma (NSCLC). Surgery is the mainstay of treatment for patients with early stage NSCLC and results in cure of about 60-80{\%} of patients with stage I (T1-2N0) disease [2]-[5].",
author = "Berman, {Stuart M.} and Mark Huberman and Armin Ernst and David Feller-Kopman and Roberts, {David H.} and Phillip Boiselle and Parker, {J. Anthony} and Danielle McDonald and Nancy Rumplik and Nedea, {Elena A.} and Simon Ashiku and Gangadharan, {Sidhu P.} and Michael Goldstein and Susan Schumer and Jain, {Sanjay R.} and Darren Brennan and Buff, {Michael S.} and Thurer, {Robert L.} and Malcolm Decamp",
year = "2007",
month = "12",
day = "1",
doi = "10.1007/978-3-540-69886-9_15",
language = "English (US)",
isbn = "9783540698852",
pages = "133--144",
booktitle = "Treating Tumors that Move with Respiration",
publisher = "Springer Berlin Heidelberg",

}

Berman, SM, Huberman, M, Ernst, A, Feller-Kopman, D, Roberts, DH, Boiselle, P, Parker, JA, McDonald, D, Rumplik, N, Nedea, EA, Ashiku, S, Gangadharan, SP, Goldstein, M, Schumer, S, Jain, SR, Brennan, D, Buff, MS, Thurer, RL & Decamp, M 2007, Selection of treatment for patients with early stage non-small cell Lung cancer in a multidisciplinary thoracic oncology program. in Treating Tumors that Move with Respiration. Springer Berlin Heidelberg, pp. 133-144. https://doi.org/10.1007/978-3-540-69886-9_15

Selection of treatment for patients with early stage non-small cell Lung cancer in a multidisciplinary thoracic oncology program. / Berman, Stuart M.; Huberman, Mark; Ernst, Armin; Feller-Kopman, David; Roberts, David H.; Boiselle, Phillip; Parker, J. Anthony; McDonald, Danielle; Rumplik, Nancy; Nedea, Elena A.; Ashiku, Simon; Gangadharan, Sidhu P.; Goldstein, Michael; Schumer, Susan; Jain, Sanjay R.; Brennan, Darren; Buff, Michael S.; Thurer, Robert L.; Decamp, Malcolm.

Treating Tumors that Move with Respiration. Springer Berlin Heidelberg, 2007. p. 133-144.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Selection of treatment for patients with early stage non-small cell Lung cancer in a multidisciplinary thoracic oncology program

AU - Berman, Stuart M.

AU - Huberman, Mark

AU - Ernst, Armin

AU - Feller-Kopman, David

AU - Roberts, David H.

AU - Boiselle, Phillip

AU - Parker, J. Anthony

AU - McDonald, Danielle

AU - Rumplik, Nancy

AU - Nedea, Elena A.

AU - Ashiku, Simon

AU - Gangadharan, Sidhu P.

AU - Goldstein, Michael

AU - Schumer, Susan

AU - Jain, Sanjay R.

AU - Brennan, Darren

AU - Buff, Michael S.

AU - Thurer, Robert L.

AU - Decamp, Malcolm

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Lung cancer is the leading cause of cancer mortality in men and women. More than 170,000 Americans receive a diagnosis of lung cancer annually and the majority of them die of the disease [1]. There is considerable interest in improving treatment for lung cancer given its high impact on society. More than 80% of patients with lung cancer have non-small cell carcinoma (NSCLC). Surgery is the mainstay of treatment for patients with early stage NSCLC and results in cure of about 60-80% of patients with stage I (T1-2N0) disease [2]-[5].

AB - Lung cancer is the leading cause of cancer mortality in men and women. More than 170,000 Americans receive a diagnosis of lung cancer annually and the majority of them die of the disease [1]. There is considerable interest in improving treatment for lung cancer given its high impact on society. More than 80% of patients with lung cancer have non-small cell carcinoma (NSCLC). Surgery is the mainstay of treatment for patients with early stage NSCLC and results in cure of about 60-80% of patients with stage I (T1-2N0) disease [2]-[5].

UR - http://www.scopus.com/inward/record.url?scp=84891435888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891435888&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-69886-9_15

DO - 10.1007/978-3-540-69886-9_15

M3 - Chapter

SN - 9783540698852

SP - 133

EP - 144

BT - Treating Tumors that Move with Respiration

PB - Springer Berlin Heidelberg

ER -

Berman SM, Huberman M, Ernst A, Feller-Kopman D, Roberts DH, Boiselle P et al. Selection of treatment for patients with early stage non-small cell Lung cancer in a multidisciplinary thoracic oncology program. In Treating Tumors that Move with Respiration. Springer Berlin Heidelberg. 2007. p. 133-144 https://doi.org/10.1007/978-3-540-69886-9_15